BRUKER CORPORATION Earnings Per Share (Diluted)
BRUKER CORPORATION (BRKR) reported Earnings Per Share (Diluted) of -$0.41 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- BRUKER CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was -$0.41, a 920.00% decline year-over-year.
- BRUKER CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was $0.02, a 81.82% decline year-over-year.
- BRUKER CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was -$0.41, a 251.85% decline year-over-year.
- BRUKER CORPORATION earnings per share, diluted for the quarter ending 2025-06-30 was $0.05, a 0.00% change year-over-year.
- BRUKER CORPORATION earnings per share, diluted for fiscal 2025 was -$0.15, a 119.74% decline from fiscal 2024.
- BRUKER CORPORATION earnings per share, diluted for fiscal 2024 was $0.76, a 73.79% decline from fiscal 2023.
- BRUKER CORPORATION earnings per share, diluted for fiscal 2023 was $2.90, a 45.73% increase from fiscal 2022.
- BRUKER CORPORATION earnings per share, diluted for fiscal 2022 was $1.99, a 9.94% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.41 10-Q · filed 2026-08-05 | -$0.39 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $0.02 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.15 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$0.41 10-Q · filed 2025-11-05 | -$0.25 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $0.05 10-Q · filed 2026-08-05 | $0.16 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $0.11 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $0.76 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $0.27 10-Q · filed 2025-11-05 | $0.67 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.05 10-Q · filed 2025-08-06 | $0.40 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | $0.35 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $2.90 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $0.60 10-Q · filed 2024-11-07 | $1.50 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.39 10-Q · filed 2024-08-09 | $0.91 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $0.52 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $1.99 10-K · filed 2025-03-03 | |||
| 2022-09-30 | $0.59 10-Q · filed 2023-11-09 | $1.33 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.33 10-Q · filed 2023-08-09 | $0.74 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $0.41 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $1.81 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $0.57 10-Q · filed 2022-11-04 | $1.32 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $0.38 10-Q · filed 2022-08-05 | $0.75 10-Q · filed 2022-08-05 | ||
| 2021-03-31 | $0.37 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $1.02 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $0.35 10-Q · filed 2021-11-05 | $0.57 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $0.16 10-Q · filed 2021-08-05 | $0.22 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.07 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | $0.44 10-K · filed 2020-03-27 | $1.26 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $0.39 10-Q · filed 2020-11-06 | $0.82 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $0.23 10-Q · filed 2020-08-07 | $0.43 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $0.20 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.50 10-K · filed 2020-03-27 | $1.14 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $0.28 10-K · filed 2020-03-27 | $0.65 10-Q · filed 2019-11-04 | ||
| 2018-06-30 | $0.20 10-K · filed 2020-03-27 | $0.37 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.17 10-K · filed 2020-03-27 | |||
| 2017-12-31 | -$0.02 10-K · filed 2019-03-01 | $0.21 derived: net income ÷ weighted average shares · filed 2020-03-27 | $0.36 derived: net income ÷ weighted average shares · filed 2020-03-27 | $0.49 10-K · filed 2020-03-27 |
| 2017-09-30 | $0.23 10-K · filed 2019-03-01 | $0.38 derived: net income ÷ weighted average shares · filed 2018-11-09 | $0.51 10-Q · filed 2018-11-09 | $0.94 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2017-06-30 | $0.15 10-K · filed 2019-03-01 | $0.28 10-Q · filed 2018-08-09 | $0.71 derived: net income ÷ weighted average shares · filed 2019-03-01 | $1.00 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2017-03-31 | $0.13 10-K · filed 2019-03-01 | $0.56 derived: net income ÷ weighted average shares · filed 2019-03-01 | $0.85 derived: net income ÷ weighted average shares · filed 2019-03-01 | $0.94 derived: net income ÷ weighted average shares · filed 2019-03-01 |
| 2016-12-31 | $0.43 10-K · filed 2018-03-16 | $0.72 derived: net income ÷ weighted average shares · filed 2019-03-01 | $0.80 derived: net income ÷ weighted average shares · filed 2019-03-01 | $0.95 10-K · filed 2019-03-01 |
| 2016-09-30 | $0.29 10-K · filed 2018-03-16 | $0.38 derived: net income ÷ weighted average shares · filed 2017-11-09 | $0.52 10-Q · filed 2017-11-09 | $0.89 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2016-06-30 | $0.09 10-K · filed 2018-03-16 | $0.23 10-Q · filed 2017-08-09 | $0.60 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.67 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2016-03-31 | $0.14 10-K · filed 2018-03-16 | $0.51 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.58 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.71 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2015-12-31 | $0.36 10-K · filed 2017-03-01 | $0.43 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.56 derived: net income ÷ weighted average shares · filed 2018-03-16 | $0.60 10-K · filed 2018-03-16 |
| 2015-09-30 | $0.07 10-K · filed 2017-03-01 | $0.20 derived: net income ÷ weighted average shares · filed 2016-11-09 | $0.24 derived: net income ÷ weighted average shares · filed 2016-11-09 | |
| 2015-06-30 | $0.13 10-K · filed 2017-03-01 | $0.17 derived: net income ÷ weighted average shares · filed 2016-08-05 | ||
| 2015-03-31 | $0.04 10-K · filed 2017-03-01 | |||
| 2014-12-31 | $0.15 10-K · filed 2016-02-29 | $0.33 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $0.03 10-K · filed 2016-02-29 | |||
| 2014-06-30 | $0.10 10-K · filed 2016-02-29 | |||
| 2014-03-31 | $0.05 10-K · filed 2016-02-29 | |||
| 2013-12-31 | $0.21 10-K · filed 2015-02-27 | $0.48 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $0.10 10-K · filed 2015-02-27 | |||
| 2013-06-30 | $0.14 10-K · filed 2015-02-27 | |||
| 2013-03-31 | $0.03 10-K · filed 2015-02-27 | |||
| 2012-12-31 | $0.08 10-K · filed 2014-02-27 | $0.46 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $0.24 10-K · filed 2014-02-27 | $0.39 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $0.06 10-K · filed 2014-02-27 | $0.15 10-Q · filed 2012-08-09 | ||
| 2012-03-31 | $0.09 10-K · filed 2014-02-27 | |||
| 2011-12-31 | $0.23 10-K · filed 2013-02-28 | $0.55 10-K · filed 2014-02-27 | ||
| 2011-09-30 | $0.12 10-K · filed 2013-02-28 | $0.32 10-Q · filed 2012-11-08 | ||
| 2011-06-30 | $0.13 10-K · filed 2013-02-28 | $0.20 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $0.07 10-K · filed 2013-02-28 | |||
| 2010-12-31 | $0.18 10-K · filed 2012-02-29 | $0.58 10-K · filed 2013-02-28 | ||
| 2010-09-30 | $0.17 10-K · filed 2012-02-29 | $0.40 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $0.14 10-K · filed 2012-02-29 | $0.23 10-Q · filed 2011-08-09 | ||
| 2010-03-31 | $0.10 10-K · filed 2012-02-29 | |||
| 2009-12-31 | $0.49 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |